CZ

Ccra Adam Zhang

Associate Director, Clinical Research at Artivion

Adam Zhang, CCRA, has a diverse range of work experience in the field of clinical research. Adam is currently working as an Associate Director of Clinical Research at Artivion, Inc. In this role, they oversee and manages various clinical research projects. Prior to this, Adam worked as a Senior Manager of Core Products at the same company. Before joining Artivion, Inc., Adam worked as a Technical Writer (CRQE Specialist II) at Frestedt Inc, where they were responsible for writing technical documents related to clinical research. Adam also worked as a Clinical Project Manager (Consultant) at Cardialen, Inc. Adam's previous roles also include being a Senior Clinical Research Associate at Vascular Dynamics, a Clinical Trial Manager at TriReme Medical, LLC, a Clinical Manager at Sano V, and a Clinical Research Associate at Cardiovascular Systems, Inc. Adam began their career as an Assistant Clinical Research Associate at RCRI, where they carried out clinical research and regulatory affairs projects. Adam also has experience as a Research Assistant and Teaching Assistant at the University of Minnesota, where they conducted immunology research and assisted in teaching.

Adam Zhang, CCRA, completed their education at the University of Minnesota. From 2004 to 2007, they earned a Bachelor's Degree in Human Physiology, with a focus on Genetics, Cell Biology, and Development. Following this, from 2007 to 2009, Adam pursued Post Baccalaureate Education in Medicine at the University of Minnesota Medical School. In addition to their academic background, Adam obtained their certification as a Certified Clinical Research Associate (CCRA) from the Association of Clinical Research Professionals in October 2014.

Links

Previous companies

University of Minnesota logo
Vascular Dynamics logo

Timeline

  • Associate Director, Clinical Research

    February, 2023 - present

  • Senior Manager Core Products

    March, 2022

  • Senior Project Manager Aortic Repair Technologies

    March, 2021

View in org chart